Liv Pure Peptide Product: Ipamorelin

Liv Pure Peptides Ipamorelin (Ipamorelin) Categories: Hormone Optimization, Fitness & Performance, Anti Aging $39.99 CAS# 170851-70-4 Formula: C38H49N9O5 Molecular Weight: 711.870 g/mol

Ipamorelin is a synthetic pentapeptide designed for precise research into growth hormone regulation. By selectively targeting the ghrelin receptor (GHS-R1a), it promotes pulsatile GH secretion without triggering unwanted hormone release, offering a clean profile for studying anabolic pathways and tissue repair. Its mode of action includes stimulating the anterior pituitary while inhibiting somatostatin, thereby enhancing IGF-1-mediated effects. Supplied in lyophilized powder form (5 mg; >98% purity), this peptide is intended for in vitro and laboratory research only.

For Research Use Only – Not for Human Consumption.

Sizes

10 mg

Liv Pure Peptides Products: Ipamorelin 5mg

At Liv Pure Peptides, innovation meets purity. Our advanced research and rigorous quality standards deliver breakthrough peptide solutions for better health and science.

Shop Products

Products

Pages

Legal

Newsletter Signup

YOU MUST BE OVER 21 YEARS OLD TO USE THIS WEBSITE.

All products provided by Liv Pure are intended solely for in‑vitro laboratory research purposes. These materials are expressly forbidden for any form of human or animal use, ingestion, or administration, and all products are sold strictly for research, laboratory, or analytical purposes – not for human consumption.

The products offered on this platform are not formulated, designed, or intended to diagnose, cure, mitigate, treat, or prevent any diseases or medical conditions. Additionally, these statements have not been evaluated by the Food and Drug Administration, and our products are not intended to diagnose, treat, cure, or prevent any disease.

All products are for Research and Development use only and are not for human consumption.

Liv Pure is a chemical supplier; LIV Pure Peptides is not a compounding pharmacy or chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act, nor is it an outsourcing facility as defined under Section 503B of the Act.